Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune response to inactivated influenza vaccine in allogeneic stem cell transplant recipients
2022-003041-35Phase 4Completed
- Sponsor
- Centre Hospitalier Universitaire de Liège
- Start
- Sep 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Fluzone Trivalent in influenza, sponsored by Centre Hospitalier Universitaire de Liège. Primary endpoints: Serological response to inactivated influenza vaccine and Cellular immune response to inactivated influenza vaccine. Started Sep 2022; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on 2022-003041-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003041-35.